Search

GlaxoSmithKline PLC

Suletud

Sektor Tervishoid

1,650 0.36

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1645.5

Max

1651.5

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+6.23 upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

30. okt 2024

Järgmine dividendimakse kuupäev

10. okt 2024

Järgmine aktsia dividendi kuupäev (ex-date)

14. nov 2024

Uudiste sentiment

By Acuity

41%

59%

97 / 365 Pingereas Healthcare

GlaxoSmithKline PLC Graafik

Seotud uudised

31. juuli 2024, 08:55 UTC

Tulu

GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales -- 2nd Update

31. juuli 2024, 07:53 UTC

Tulu

GSK Lifts Guidance After HIV, Cancer Treatments Boost Sales -- Update

31. juuli 2024, 06:46 UTC

Tulu

GSK Lifts Guidance After Higher Turnover Beats Market Views

16. aug 2024, 09:30 UTC

Market Talk

GSK's Latest Zantac Trial Win Is a Positive Twist But Concerns Linger -- Market Talk

1. aug 2024, 10:30 UTC

Peamised uudised

Moderna Cuts Revenue Guidance Amid Steeper Competition -- Barrons.com

31. juuli 2024, 10:17 UTC

Market Talk
Tulu

GSK's Vaccine Arm Overshadows 2Q Beat, Guidance Lift -- Market Talk

31. juuli 2024, 09:58 UTC

Market Talk
Tulu

GSK's Vaccines-Sales Warning in Focus Amid 2Q Results -- Market Talk

31. juuli 2024, 09:17 UTC

Market Talk
Tulu

GSK's Shingrix Miss Stands out Among 2Q Results -- Market Talk

31. juuli 2024, 08:03 UTC

Market Talk
Tulu

GSK Results Look Solid But Vaccine Portfolio Worries -- Market Talk

31. juuli 2024, 06:34 UTC

Tulu

Correct: GSK PLC 2Q Adj EPS 43.4p

31. juuli 2024, 06:05 UTC

Tulu

GSK PLC 2Q Adj EPS 43.3p

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Had Seen 2024 Adj EPS Growth of 8% to 10%

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Sees 2024 Adj EPS Growth of 10% to 12%

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Had Seen 2024 Adjusted Operating Profit Growth Between 9% to 11%

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Sees 2024 Adjusted Operating Profit Growth Between 11% and 13%

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Had Seen 2024 Turnover Growth Toward Higher End of 5% to 7% Range

31. juuli 2024, 06:04 UTC

Tulu

GSK PLC Sees 2024 Turnover Growth Between 7% to 9% Range

31. juuli 2024, 06:03 UTC

Tulu

GSK PLC Raises 2024 View

31. juuli 2024, 06:03 UTC

Tulu

GSK PLC Sees 2024 Dividend of 60p a Share

31. juuli 2024, 06:03 UTC

Tulu

GSK PLC Declares Dividend of 15p

31. juuli 2024, 06:03 UTC

Tulu

GSK PLC 2Q Adj Oper Pft GBP2.51B

31. juuli 2024, 06:01 UTC

Tulu

GSK PLC 2Q Turnover Consensus Was GBP7.51B

31. juuli 2024, 06:01 UTC

Tulu

GSK PLC 2Q Net Pft Consensus Was GBP1.59B

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q Turnover GBP7.88B

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q Net Pft GBP1.17B

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q EPS 28.5p

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q Pre-items, Pretax Pft GBP2.36B

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q Pretax Pft GBP1.5B

31. juuli 2024, 06:00 UTC

Tulu

GSK PLC 2Q Oper Pft GBP1.65B

5. juuli 2024, 06:20 UTC

Market Talk

GSK's RSV Vaccine Sales Outlook Dims After CDC's Narrowed Recommendation -- Market Talk

GlaxoSmithKline PLC Prognoos

Hinnasiht

By TipRanks

6.23% tõus

12 kuu keskmine prognoos

Keskmine 1,754.33 GBX  6.23%

Kõrge 2,100 GBX

Madal 1,500 GBX

Põhineb 14 Wall Streeti analüütiku instrumendi GlaxoSmithKline PLC 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

6

Osta

6

Hoia

2

Müü

Sentiment

By Acuity

97 / 365 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise